Michael H. Serrano‐Wu

Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect

Min Gao, Richard E. Nettles, Makonen Belema et al. · Nature · 2010 · 929 citations · Full text

Hcv Ns5a Inhibitor, Viral Hepatitis, Medicine +10

Identification of Hepatitis C Virus NS5A Inhibitors

Julie A. Lemm, Donald R. O’Boyle, Mengping Liu et al. · Journal of Virology · 2009 · 193 citations · Full text

Large-scale chemical–genetics yields new M. tuberculosis inhibitor classes

Eachan O. Johnson, Emily LaVerriere, Emma Office et al. · Nature · 2019 · 173 citations · Full text

Medicinal Chemistry, Antimicrobial Drug Discovery, Pulmonary Tuberculosis +9

Inhibitors of HCV NS5A: From Iminothiazolidinones to Symmetrical Stilbenes

J. Romine, Denis R. St. Laurent, John E. Leet et al. · ACS Medicinal Chemistry Letters · 2011 · 85 citations · Full text

Medicinal Chemistry, Bioorganic Chemistry, Hcv Ns5a +13

Discovery of Potent Hepatitis C Virus NS5A Inhibitors with Dimeric Structures

Julie A. Lemm, John E. Leet, Donald R. O’Boyle et al. · Antimicrobial Agents and Chemotherapy · 2011 · 57 citations · Full text